Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Biohaven Pharmaceuticals, Inc.)"
Count: 37
Selected: 0
NCT IDTitle
NCT05046613Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
NCT05086094Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)
NCT04987944Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma
NCT04743141Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
NCT04708834Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
NCT04693351Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder
NCT04641143Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
NCT04634435Autologous Memory-like NK Cell Therapy With BHV-1100 (Formerly KP1237), Low Dose IL-2 in Multiple Myeloma Patients
NCT04574362Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine
NCT04571060Randomized Trial in Adult Subjects With Acute Migraines
NCT04408794Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
NCT04346615Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen
NCT03952806Study of BHV-3241 in Subjects With Multiple System Atrophy
NCT03941834Trial for Treatment Refractory Trigeminal Neuralgia
NCT03934086An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine
NCT03872453Acute Treatment Trial in Adult Subjects With Migraines
NCT03829241Randomized Trial of Adult Subjects With Generalized Anxiety Disorder
NCT03732638Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
NCT03701399Troriluzole in Adult Subjects With Spinocerebellar Ataxia
NCT03605667Study of BHV-4157 in Alzheimer's Disease
NCT03537807Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT03520517Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
NCT03461757Trial in Adult Subjects With Acute Migraines
NCT03299166BHV-4157 in Adult Subjects With Obsessive Compulsive Disorder
NCT03266588Open Label Safety Study in Acute Treatment of Migraine
NCT03237845Safety and Efficacy in Adult Subjects With Acute Migraines
NCT03235479Safety and Efficacy Study in Adult Subjects With Acute Migraines
NCT02960893Trial in Adult Subjects With Spinocerebellar Ataxia
NCT01445067Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition
NCT01430442Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine
NCT04899921Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
NCT04629950Rimegepant in Moderate Plaque-type Psoriasis
NCT04616456Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
NCT04436510HEALEY ALS Platform Trial - Regimen B Verdiperstat
NCT03017508Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder
NCT04804033A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
NCT04649242Randomized Study in Children and Adolescents With Migraine: Acute Treatment